一种马铃薯三糖齐墩果酸皂苷衍生物及其制备方法和应用
本发明属于药物化学技术领域，具体涉及一种马铃薯三糖齐墩果酸皂苷衍生物及其制备方法和应用。实验研究发现，本发明提供的马铃薯三糖齐墩果酸皂苷衍生物对新型冠状病毒SARS‑CoV‑2具有显著的抑制作用，可应用于制备治疗新型冠状病毒肺炎药物中；其中，部分马铃薯三糖齐墩果酸皂苷衍生物对新型冠状病毒的抑制效果IC50达到了10μM以下，具有非常好的开发潜力，为治疗新型冠状病毒提供了更多的选择。.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 24. Dez. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Chinesisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-12-24, Last update posted on www.tib.eu: 2022-07-13, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
CN112457363 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011905441 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011905441 | ||
| 003 | DE-627 | ||
| 005 | 20230504151221.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210729s2021 xx |||||o 00| ||chi c | ||
| 035 | |a (DE-627)EPA011905441 | ||
| 035 | |a (EPA)CN112457363 | ||
| 035 | |a (EPA)74800005 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 245 | 1 | 0 | |a 一种马铃薯三糖齐墩果酸皂苷衍生物及其制备方法和应用 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-12-24, Last update posted on www.tib.eu: 2022-07-13, Last updated: 2023-02-09 | ||
| 520 | |a 本发明属于药物化学技术领域，具体涉及一种马铃薯三糖齐墩果酸皂苷衍生物及其制备方法和应用。实验研究发现，本发明提供的马铃薯三糖齐墩果酸皂苷衍生物对新型冠状病毒SARS‑CoV‑2具有显著的抑制作用，可应用于制备治疗新型冠状病毒肺炎药物中；其中，部分马铃薯三糖齐墩果酸皂苷衍生物对新型冠状病毒的抑制效果IC50达到了10μM以下，具有非常好的开发潜力，为治疗新型冠状病毒提供了更多的选择。 | ||
| 650 | 4 | |a C07H: Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d;aldonic acids, saccharic acids c07c0059105000, c07c0059285000;cyanohydrins c07c0255160000;glycals c07d;compounds of unknown constitution c07g;polysaccharides, derivatives thereof c08b;dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000;sugar industry c13) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C07J: Steroids (seco-steroids c07c) | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 24. Dez. |
| 773 | 1 | 8 | |g year:2021 |g day:24 |g month:12 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/74800005/publication/CN112457363A1?q=CN112457363 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2021 |b 24 |c 12 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 24 |c 12 | ||